Skip to main content

Advertisement

SpringerLink
Log in

Bilateral Neck Exploration in Primary Hyperparathyroidism—When Is It Selected and How Is It Performed?

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Although most patients with primary hyperparathyroidism (PHPT) are ideal candidates for minimally invasive parathyroidectomy, some will have more than one enlarged gland and require bilateral neck exploration to achieve biochemical cure. We evaluated the clinical evidence for when to choose bilateral neck exploration for patients with PHPT.

Methods

We searched PubMed for English-language studies published from 1996 to 2008. The level of clinical evidence was determined according to the criteria proposed by Sackett (Chest 95[2 Suppl]:2S, 1989), and the grade of recommendation was established according to the criteria proposed by Heinrich et al. (Ann Surg 243:154, 2006).

Results

Level III–IV evidence shows that patients with multiple endocrine neoplasia (MEN) 1 and PHPT should have a bilateral neck exploration (grade C recommendation). Only level IV evidence indicates that patients with familial PHPT should do so (no recommendation). Although most patients with MEN 2A have single-gland disease, bilateral neck exploration is still indicated, because they will have either a therapeutic or prophylactic total thyroidectomy for medullary thyroid cancer. A history of head and neck irradiation is associated with PHPT, but the risk of multi-gland parathyroid disease is apparently no higher than in sporadic cases (level IV evidence, no recommendation). Previous or current lithium therapy confers a higher risk of multi-gland disease (25%–45%; level IV–V evidence), which may require bilateral neck exploration. Preoperative localizing studies reliably identify most patients with single-gland but not multi-gland disease (level II–IV evidence). Negative localizing studies confer an approximately 50% risk of multi-gland disease and indicate that bilateral neck exploration is necessary. If two localizing studies are concordant, few patients will require bilateral neck exploration (level IV, no recommendation).

Conclusions

No level I or II evidence reliably identifies preoperative clinical risk factors for determining which patients should have routine bilateral neck exploration for multi-gland disease or for intraoperative decision making to convert to bilateral neck exploration. Imaging studies are positive in most patients (level II). No randomized studies exist to determine when a bilateral neck exploration is indicated based on clinical risk factors or imaging studies that may suggest multi-gland disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kebebew E, Clark OH (1998) Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am 7:721

    PubMed  CAS  Google Scholar 

  2. Mack LA, Pasieka JL (2004) Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg Clin N Am 84:803

    Article  PubMed  Google Scholar 

  3. Sackett WR, Barraclough B, Reeve TS et al (2002) Worldwide trends in the surgical treatment of primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Arch Surg 137:1055

    Article  PubMed  Google Scholar 

  4. Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543

    Article  PubMed  Google Scholar 

  5. Irvin GL 3rd, Dembrow VD, Prudhomme DL (1993) Clinical usefulness of an intraoperative “quick parathyroid hormone” assay. Surgery 114:1019

    PubMed  Google Scholar 

  6. Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95(2 Suppl):2S

    Article  PubMed  CAS  Google Scholar 

  7. Heinrich S, Schafer M, Rousson V et al (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243:154

    Article  PubMed  Google Scholar 

  8. Lairmore TC, Piersall LD, DeBenedetti MK et al (2004) Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 239:637

    Article  PubMed  Google Scholar 

  9. Doherty GM, Lairmore TC, DeBenedetti MK (2004) Multiple endocrine neoplasia type 1 parathyroid adenoma development over time. World J Surg 28:1139

    Article  PubMed  Google Scholar 

  10. Kraimps JL, Duh QY, Demeure M et al (1992) Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 112:1080

    PubMed  CAS  Google Scholar 

  11. Wells SA Jr, Farndon JR, Dale JK et al (1980) Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg 192:451

    PubMed  Google Scholar 

  12. Lee CH, Tseng LM, Chen JY et al (2006) Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol 13:103

    Article  PubMed  Google Scholar 

  13. Lambert LA, Shapiro SE, Lee JE et al (2005) Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 140:374

    Article  PubMed  Google Scholar 

  14. Elaraj DM, Skarulis MC, Libutti SK et al (2003) Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 134:858

    Article  PubMed  Google Scholar 

  15. Arnalsteen LC, Alesina PF, Quiereux JL et al (2002) Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 132:1119

    Article  PubMed  Google Scholar 

  16. Norton JA, Venzon DJ, Berna MJ et al (2008) Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg 247:501

    Article  PubMed  Google Scholar 

  17. Hubbard JG, Sebag F, Maweja S et al (2006) Subtotal parathyroidectomy as an adequate treatment for primary hyperparathyroidism in multiple endocrine neoplasia type 1. Arch Surg 141:235

    Article  PubMed  Google Scholar 

  18. Sarquis MS, Silveira LG, Pimenta FJ et al (2008) Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery 143:630

    Article  PubMed  Google Scholar 

  19. Bano G, Mansour S, Nussey S (2008) The association of primary hyperparathyroidism and primary ovarian failure: a de novo t(X; 2) (q22p13) reciprocal translocation. Eur J Endocrinol 158:261

    Article  PubMed  CAS  Google Scholar 

  20. Huang SM, Duh QY, Shaver J et al (1997) Familial hyperparathyroidism without multiple endocrine neoplasia. World J Surg 21:22

    Article  PubMed  CAS  Google Scholar 

  21. Allo M, Thompson NW (1982) Familial hyperparathyroidism caused by solitary adenomas. Surgery 92:486

    PubMed  CAS  Google Scholar 

  22. Carneiro DM, Irvin GL 3rd, Inabnet WB (2002) Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery 132:1050

    Article  PubMed  Google Scholar 

  23. Herfarth KK, Bartsch D, Doherty GM (1996) Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 120:966

    Article  PubMed  CAS  Google Scholar 

  24. Eng C, Clayton D, Schuffenecker I et al (1996) The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 276:1575

    Article  PubMed  CAS  Google Scholar 

  25. Frank-Raue K, Hoppner W, Frilling A et al (1996) Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab 81:1780

    Article  PubMed  CAS  Google Scholar 

  26. Dotzenrath C, Cupisti K, Goretzki PE et al (2001) Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia types I and IIa: is a more or less extended operation essential? Eur J Surg 167:173

    Article  PubMed  CAS  Google Scholar 

  27. Decker RA, Geiger JD, Cox CE et al (1996) Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated? World J Surg 20:814

    Article  PubMed  CAS  Google Scholar 

  28. Stephen AE, Chen KT, Milas M et al (2004) The coming of age of radiation-induced hyperparathyroidism: evolving patterns of thyroid and parathyroid disease after head and neck irradiation. Surgery 136:1143

    Article  PubMed  Google Scholar 

  29. Tezelman S, Rodriguez JM, Shen W et al (1995) Primary hyperparathyroidism in patients who have received radiation therapy and in patients who have not received radiation therapy. J Am Coll Surg 180:81

    PubMed  CAS  Google Scholar 

  30. Hedman I, Hansson G, Lundberg LM et al (1984) A clinical evaluation of radiation-induced hyperparathyroidism based on 148 surgically treated patients. World J Surg 8:96

    Article  PubMed  CAS  Google Scholar 

  31. Abdullah H, Bliss R, Guinea AI et al (1999) Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 86:91

    Article  PubMed  CAS  Google Scholar 

  32. Bendz H, Sjodin I, Toss G et al (1996) Hyperparathyroidism and long-term lithium therapy—a cross-sectional study and the effect of lithium withdrawal. J Intern Med 240:357

    Article  PubMed  CAS  Google Scholar 

  33. Carchman E, Ogilvie J, Holst J et al (2008) Appropriate surgical treament of lithium-associated hyperparathyroidism. World J Surg 32:2195

    Article  PubMed  Google Scholar 

  34. Awad SS, Miskulin J, Thompson N (2003) Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27:486

    Article  PubMed  Google Scholar 

  35. Coakley AJ, Kettle AG, Wells CP et al (1989) 99Tcm sestamibi—a new agent for parathyroid imaging. Nucl Med Commun 10:791

    Article  PubMed  CAS  Google Scholar 

  36. Sharma J, Mazzaglia P, Milas M et al (2006) Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99 m sestamibi modality? Surgery 140:856

    Article  PubMed  Google Scholar 

  37. Denham DW, Norman J (1998) Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon’s choice of operative procedure. J Am Coll Surg 186:293

    Article  PubMed  CAS  Google Scholar 

  38. Gupta VK, Yeh KA, Burke GJ et al (1998) 99 m-Technetium sestamibi localized solitary parathyroid adenoma as an indication for limited unilateral surgical exploration. Am J Surg 176:409

    Article  PubMed  CAS  Google Scholar 

  39. Saint Marc O, Cogliandolo A, Pidoto RR et al (2004) Prospective evaluation of ultrasonography plus MIBI scintigraphy in selecting patients with primary hyperparathyroidism for unilateral neck exploration under local anaesthesia. Am J Surg 187:388

    Article  PubMed  Google Scholar 

  40. Arici C, Cheah WK, Ituarte PH et al (2001) Can localization studies be used to direct focused parathyroid operations? Surgery 129:720

    Article  PubMed  CAS  Google Scholar 

  41. Song AU, Phillips TE, Edmond CV et al (1999) Success of preoperative imaging and unilateral neck exploration for primary hyperparathyroidism. Otolaryngol Head Neck Surg 121:393

    Article  PubMed  CAS  Google Scholar 

  42. Pellitteri PK (2003) Directed parathyroid exploration: evolution and evaluation of this approach in a single-institution review of 346 patients. Laryngoscope 113:1857

    Article  PubMed  Google Scholar 

  43. Sprouse LR 2nd, Roe SM, Kaufman HJ et al (2001) Minimally invasive parathyroidectomy without intraoperative localization. Am Surg 67:1022

    PubMed  Google Scholar 

  44. Jacobson SR, van Heerden JA, Farley DR et al (2004) Focused cervical exploration for primary hyperparathyroidism without intraoperative parathyroid hormone monitoring or use of the gamma probe. World J Surg 28:1127

    Article  PubMed  Google Scholar 

  45. Miller P, Kindred A, Kosoy D et al (2003) Preoperative sestamibi localization combined with intraoperative parathyroid hormone assay predicts successful focused unilateral neck exploration during surgery for primary hyperparathyroidism. Am Surg 69:82

    PubMed  Google Scholar 

  46. Bergenfelz A, Tennvall J, Valdermarsson S et al (1997) Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: a prospective comparative study in patients with predominantly mild primary hyperparathyroidism. Surgery 121:601

    Article  PubMed  CAS  Google Scholar 

  47. Siperstein A, Berber E, Mackey R et al (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872

    Article  PubMed  Google Scholar 

  48. Gauger PG, Agarwal G, England BG et al (2001) Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery 130:1005

    Article  PubMed  CAS  Google Scholar 

  49. Gordon LL, Snyder WH 3rd, Wians F Jr et al (1999) The validity of quick intraoperative parathyroid hormone assay: an evaluation in seventy-two patients based on gross morphologic criteria. Surgery 126:1030

    Article  PubMed  CAS  Google Scholar 

  50. Norman JG, Jaffray CE, Chheda H (2000) The false-positive parathyroid sestamibi: a real or perceived problem and a case for radioguided parathyroidectomy. Ann Surg 231:31

    Article  PubMed  CAS  Google Scholar 

  51. Taillefer R, Boucher Y, Potvin C et al (1992) Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99 m-sestamibi (double-phase study). J Nucl Med 33:1801

    PubMed  CAS  Google Scholar 

  52. Rodgers SE, Hunter GJ, Hamberg LM et al (2006) Improved preoperative planning for directed parathyroidectomy with 4-dimensional computed tomography. Surgery 140:932

    Article  PubMed  Google Scholar 

  53. Goldstein RE, Carter WM 2nd, Fleming M (2006) Unilateral cervical surgical exploration aided by intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and equivocal sestamibi scan results. Arch Surg 141:552

    Article  PubMed  Google Scholar 

  54. Lal A, Chen H (2007) The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible? Ann Surg Oncol 14:2363

    Article  PubMed  Google Scholar 

  55. Scheiner JD, Dupuy DE, Monchik JM et al (2001) Pre-operative localization of parathyroid adenomas: a comparison of power and colour Doppler ultrasonography with nuclear medicine scintigraphy. Clin Radiol 56:984

    Article  PubMed  CAS  Google Scholar 

  56. Miura D, Wada N, Arici C et al (2002) Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy? World J Surg 26:926

    Article  PubMed  Google Scholar 

  57. Gawande AA, Monchik JM, Abbruzzese TA et al (2006) Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg 141:381

    Article  PubMed  CAS  Google Scholar 

  58. Kebebew E, Hwang J, Reiff E et al (2006) Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 141:777

    Article  PubMed  Google Scholar 

  59. Smit PC, Borel Rinkes IH et al (2000) Direct, minimally invasive adenomectomy for primary hyperparathyroidism: an alternative to conventional neck exploration? Ann Surg 231:559

    Article  PubMed  CAS  Google Scholar 

  60. van Dalen A, Smit CP, van Vroonhoven TJ et al (2001) Minimally invasive surgery for solitary parathyroid adenomas in patients with primary hyperparathyroidism: role of US with supplemental CT. Radiology 220:631

    Article  PubMed  Google Scholar 

  61. Chiu B, Sturgeon C, Angelos P (2006) Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg 141:483

    Article  PubMed  Google Scholar 

  62. Carneiro DM, Solorzano CC, Nader MC et al (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134:973

    Article  PubMed  Google Scholar 

  63. Agarwal G, Barakate MS, Robinson B et al (2001) Intraoperative quick parathyroid hormone versus same-day parathyroid hormone testing for minimally invasive parathyroidectomy: a cost-effectiveness study. Surgery 130:963

    Article  PubMed  CAS  Google Scholar 

  64. Libutti SK, Alexander HR, Bartlett DL et al (1999) Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. Surgery 126:1145

    Article  PubMed  CAS  Google Scholar 

  65. Weber CJ, Ritchie JC (1999) Retrospective analysis of sequential changes in serum intact parathyroid hormone levels during conventional parathyroid exploration. Surgery 126:1139

    Article  PubMed  CAS  Google Scholar 

  66. Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: a study of 200 consecutive cases. Clin Chem 46:1662

    PubMed  CAS  Google Scholar 

  67. Di Stasio E, Carrozza C, Pio Lombardi C et al (2007) Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem 40:595

    Article  PubMed  CAS  Google Scholar 

  68. Karakousis GC, Han D, Kelz RR et al (2007) Interpretation of intra-operative PTH changes in patients with multi-glandular primary hyperparathyroidism (pHPT). Surgery 142:845

    Article  PubMed  Google Scholar 

  69. Haciyanli M, Lal G, Morita E et al (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739

    Article  PubMed  Google Scholar 

  70. Powell AC, Alexander HR, Pingpank JF et al (2008) The utility of routine transcervical thymectomy for multiple endocrine neoplasia 1-related hyperparathyroidism. Surgery 144:878

    Article  PubMed  Google Scholar 

  71. Ferolla P, Falchetti A, Filosso P et al (2005) Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 90:2603

    Article  PubMed  CAS  Google Scholar 

  72. Lim LC, Tan MH, Eng C et al (2006) Thymic carcinoid in multiple endocrine neoplasia 1: genotype–phenotype correlation and prevention. J Intern Med 259:428

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors thank Ms. Pamela Derish for her editorial review of our manuscript and helpful suggestions.

Author information

Authors and Affiliations

  1. Department of Surgery, University of California, San Francisco, Box 1674, San Francisco, CA, 94143, USA

    Jacob Moalem, Marlon Guerrero & Electron Kebebew

  2. UCSF Comprehensive Cancer Center, University of California, San Francisco, Box 0128, San Francisco, CA, 94143, USA

    Electron Kebebew

Authors
  1. Jacob Moalem
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marlon Guerrero
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Electron Kebebew
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Electron Kebebew.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moalem, J., Guerrero, M. & Kebebew, E. Bilateral Neck Exploration in Primary Hyperparathyroidism—When Is It Selected and How Is It Performed?. World J Surg 33, 2282–2291 (2009). https://doi.org/10.1007/s00268-009-9941-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-9941-5

Keywords

Search

Navigation